ACXP Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	301 340
Średni wolumen	75 472.00
Kapitalizacja rynkowa	44.20M
EPS	$-282.95 ( 2024-05-15 )
Następna data zysków	( $-0.280 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.36
ATR14	$0.0370 (1.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-23	Luci David P	Buy	250 000	Stock Option
2024-02-23	Shawah Robert G.	Buy	145 000	Stock Option
2024-02-23	Deluccia Robert J	Buy	250 000	Stock Option
2024-01-19	Sailer Carl	Buy	19 737	Common Stock
2024-01-19	Sailer Carl	Sell	19 737	Warrants for Common Stock

INSIDER POWER
76.59
Last 61 transactions
Buy: 3 435 791 \| Sell: 229 212

Wolumen Korelacja

Długi: -0.13 (neutral)

Krótki: -0.07 (neutral)

Signal:(64.884) Neutral

Acurx Pharmaceuticals, Korelacja

10 Najbardziej pozytywne korelacje
BNRG	0.947
QNRX	0.945
RMCF	0.944
AGFY	0.94
ACAD	0.94
FLGT	0.939
FWRD	0.938
SINT	0.937
AMPH	0.935
GOVX	0.931

10 Najbardziej negatywne korelacje
KINS	-0.953
GHRS	-0.943
TAYD	-0.932
ESTA	-0.931
CHW	-0.928
MMYT	-0.928
AMZN	-0.928
CRBP	-0.926
ALLT	-0.924
ROAD	-0.923

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acurx Pharmaceuticals, Korelacja - Waluta/Towar

-0.28
( neutral )

-0.17
( neutral )

0.00
( neutral )

0.16
( neutral )

0.59
( weak )

-0.34
( neutral )

Acurx Pharmaceuticals, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.150

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.150

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.120

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.490

Financial Reports:

No articles found.

Acurx Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Acurx Pharmaceuticals,

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.